The Evidence

Can repeated exposure make MCS worse?

Repeated exposure is associated with symptom recurrence, worsening, and spreading in many MCS histories, and sensitization is a credible biological framework. But every exposure has not been shown to cause permanent ratcheting damage. The safe evidence-based position is to reduce exposures that repeatedly make a person ill while studying why some people stabilize or regain tolerance.

People with MCS often describe recurrence, worsening, and a widening circle of triggers after repeated exposures. That pattern deserves protection, not a reflexive instruction to “push through” exposures. The evidence does not show that every exposure causes permanent damage, but it does support taking exposure-linked worsening seriously.

The short answer

Repeated exposure is associated with symptom recurrence, worsening, and spreading in many MCS histories, and sensitization is a credible biological framework for that pattern. What has not been shown is that every exposure produces irreversible worsening. The safe conclusion is not “push through it” and not “every exposure permanently ratchets the illness tighter.” It is to reduce exposures that repeatedly make a person ill while research determines why some people stabilize or later regain tolerance.

The useful scientific question is not whether patients should ignore reproducible reactions. It is why repeated exposure deepens sensitivity in some circumstances, why some people later stabilize or regain tolerance, and which biological states distinguish those trajectories.

What we know

The 1999 consensus definition of MCS was built around a reproducible pattern: symptoms recur with repeated chemical exposures, occur at low levels, involve multiple unrelated chemicals and multiple organ systems, and improve or resolve when incitants are removed. That definition itself does not prove a worsening mechanism, but it establishes that exposure and symptom recurrence are central to the clinical pattern.

In a 2003 survey of 917 people with self-reported MCS, respondents commonly described sensitivities spreading over time, first to related chemicals and then to other classes. The same survey found chemical avoidance and a chemical-free living space were the two highest-rated management approaches. Because this was self-report, it cannot tell us whether every new trigger represents the same biology or whether avoidance itself changed the course. But it documents a pattern that patients and clinicians have described for decades.

Laboratory work has also explored “sensitization” - an increase in physiological responsiveness after repeated or intermittent stimulation. In chemically intolerant participants, Bell and colleagues reported changes in EEG activity and blood pressure across repeated exposure sessions that were interpreted as compatible with neural sensitization. Animal work has shown that some irritant mixtures can produce progressively larger sensory responses even when the exposure concentration is held constant. Those models show that biological response gain can change with repeated exposure; they do not prove that the same process explains every case of human MCS.

What the evidence shows

The evidence supports three conclusions at once. First, worsening and “spreading” are genuine patterns reported in MCS. Second, biological sensitization is a plausible mechanism for at least part of that pattern. Third, neither point proves that every exposure produces irreversible worsening.

The 2026 five-person n-butanol paper does not weaken the case for protecting patients from exposures that repeatedly make them ill. Its uncontrolled design cannot establish that repeated exposure improved MCS, restored generalized tolerance, or caused the observed change. It should not be used as evidence for exposure therapy or against exposure reduction.

The actual unresolved question is why sensitivity deepens in some circumstances and later eases in others. Dose, timing, recovery time, the trigger itself, baseline severity, autonomic state, prior exposures, and biological subtype may all matter. The evidence does not justify deliberately provoking severe reactions in order to find out.

Why “just expose yourself” is not evidence-based advice

The five-person paper should not be turned into advice for people with MCS to deliberately expose themselves. It did not establish treatment efficacy or safety for consensus-defined MCS. Real-world exposures involve mixtures, unknown concentrations, asthma, autonomic instability, mast-cell symptoms, and other risks that were not answered by that case series.

The only defensible lesson from that tiny uncontrolled paper is methodological: a five-person observation cannot answer the treatment question. It should not be turned into a recommendation for deliberate exposure.

What the registry is answering

The Canary Registry should measure progression rather than assume it. For each participant we need the order in which trigger classes appeared, the interval between them, the intensity and duration of reactions, whether exposure reduction changed the pattern, and whether later re-exposure produced the same, weaker, or stronger response.

We also need to distinguish a person who acquired three new trigger categories in six months from a person whose original triggers simply became easier to recognize. Those are not necessarily the same phenomenon. The registry should ask about periods of stabilization and regained tolerance just as carefully as periods of worsening.

A future Recovery Phenotype study can then compare the people who spread rapidly with those who stabilize or regain tolerance. That is where variables such as autonomic symptoms, MCAS, prior TBI, PTSD, infections, sleep, exposure burden, treatment, and nervous-system interventions become potentially informative rather than speculative.

Where we stand

Repeated exposure can be associated with worsening and broader sensitivity in MCS, and sensitization is a credible biological framework for understanding that pattern. But worsening is not universal, every exposure is not proven to cause permanent injury, and the possibility of regained tolerance is real.

Our position is therefore neither “push through it” nor “every exposure makes you permanently worse.” It is: reduce exposures that repeatedly make you ill, do not deliberately provoke severe reactions on your own, and study the conditions under which sensitivity deepens, stabilizes, or reverses. The goal is not lifelong avoidance. The goal is restored function and, where possible, restored tolerance.

Sources and notes

These references support the specific claims discussed above. Study populations and limitations are described in the article; inclusion here does not mean every study used the 1999 consensus case definition.

Multiple Chemical Sensitivity: a 1999 consensus. Arch Environ Health. 1999;54(3):147-149. PMID: 10444033.

Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environ Health Perspect. 2003;111(12):1498-1504. PMID: 12948890.

Bell IR, Baldwin CM, Schwartz GE. Sensitization studies in chemically intolerant individuals: implications for individual difference research. Ann N Y Acad Sci. 2001;933:38-47. PMID: 12000034.

Bell IR et al. Patterns of waking EEG spectral power in chemically intolerant individuals during repeated chemical exposures. Int J Neurosci. 1999/2000. PMID: 10681117.

Alarie Y et al. Sensory irritation and multiple chemical sensitivity. Environ Health Perspect. 1999. PMID: 10416286.

Exposure-Based Treatment of Chemical Intolerance - A Multiple Case Study. Hygiene and Environmental Health Advances. 2026; article 100196. DOI: 10.1016/j.heha.2026.100196.

We followed the evidence. Here’s where it leads →

Sources

Sources

1Multiple Chemical Sensitivity: A 1999 Consensus. Archives of Environmental Health. 1999;54(3):147–149. PMID: 10444033. DOI: 10.1080/00039899909602251.
2Molot J, Sears M, Anisman H. Multiple chemical sensitivity: It's time to catch up to the science. Neuroscience & Biobehavioral Reviews. 2023;151:105227. DOI: 10.1016/j.neubiorev.2023.105227.
3Davidoff AL, Keyl PM, Meggs W. Development of multiple chemical sensitivities in laborers after acute gasoline fume exposure in an underground tunneling operation. Archives of Environmental Health. 1998;53:183-189.
4Rossi S, Pitidis A. Multiple Chemical Sensitivity: Review of the State of the Art in Epidemiology, Diagnosis, and Future Perspectives. Journal of Occupational and Environmental Medicine. 2017;60(2):138-146. PMID: 29111991. DOI: 10.1097/JOM.0000000000001215.
5Black DW, Okiishi C, Schlosser S. The Iowa follow-up of chemically sensitive persons. Annals of the New York Academy of Sciences. 2001;933:48-56.
6Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environmental Health Perspectives. 2003;111(12):1498–1504. PMID: 12948890.
7Saito M, Kumano H, Yoshiuchi K, et al. Symptom profile of multiple chemical sensitivity in actual life. Psychosomatic Medicine. 2005. PMID: 15784800. DOI: 10.1097/01.psy.0000155676.69030.28.
8Ternesten-Hasséus E, Bende M, Millqvist E. Increased capsaicin cough sensitivity in patients with multiple chemical sensitivity. Journal of Occupational and Environmental Medicine. 2002;44:1012-1017.
9Miller CS. Toxicant-induced loss of tolerance. Addiction. 2001;96(1):115-137. PMID: 11177524. DOI: 10.1046/j.1360-0443.2001.9611159.x.
← Back to MCSDisability.com
↑